Cladosporium Allergy Shots: Highest Spore Count, Lowest Evidence
Cladosporium herbarum allergy shots are supported by only one small early trial (Dreborg 1986, 16 children) and are not recommended by AAAAI/ACAAI or EAACI consensus — despite Cladosporium being the most abundant fungal genus in outdoor air worldwide with counts reaching 50,000 spores/m³.
Cladosporium Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to cladosporium — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of cladosporium allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of cladosporium immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of cladosporium extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for cladosporium allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing cladosporium extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription cladosporium immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat cladosporium allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Cladosporium?
The biology, taxonomy, and clinical fingerprint of Cladosporium — the foundation of how SCIT targets it.
Cladosporium herbarum colonies — olive-green to dark brown. Psychrophilic growth down to −6°C; counts 15,000–50,000 spores/m³ at summer peak.
- Scientific name
- Cladosporium herbarum / Cladosporium cladosporioides
- Family
- DavidiellaceaeCapnodiales, Dothideomycetes, Ascomycota
- Type
- Outdoor and indoor dematiaceous mold — primarily seasonal
- Native to
- Cosmopolitan; found on plant surfaces, soil, and indoor environments worldwide
- Allergen proteins
- Cla h 8 (major) — 29.5 kDa NADP-mannitol dehydrogenase; 57% IgE recognition (Simon-Nobbe 2008)Cla h 6 — enolase, pan-fungal cross-reactive with Alt a 6 and other fungal enolasesCla h 9 — serine protease; cross-reacts with Asp f 18 and Pen ch 18
- Particle size
- 3–5 µm aerodynamic diameter (range 3–35 µm) — highly respirable, alveolar penetration possible
- Avoidance difficulty
- Very difficult
How Cladosporium Allergy Presents
Symptoms by body system — useful for distinguishing Cladosporium sensitivity from overlapping allergies and infections.
Respiratory
- Allergic rhinitis — sneezing, congestion, and watery discharge peaking in summer
- Asthma exacerbation triggered by outdoor spore counts above 3,000 spores/m³
- Chronic cough correlating with high summer outdoor mold counts
- Thunderstorm-related wheeze in patients co-sensitized to both Cladosporium and Alternaria
Ocular
- Allergic conjunctivitis — itching, redness, and tearing during summer mold peaks
- Bilateral chemosis on high-count afternoons outdoors
- Periorbital puffiness after extended outdoor exposure
Dermal
- Eczema flares in atopic-dermatitis patients correlating with Cladosporium season
- Contact urticaria from direct contact with decaying plant matter
- Skin prick test reactions — wheal-flare with non-standardized extract
Systemic
- Co-sensitization with Alternaria dramatically amplifies thunderstorm-asthma risk (OR 63.97 vs 9.31 for Alternaria alone, Pulimood 2007)
- Fatigue and cognitive fog during sustained high-count summer periods
- Hypersensitivity pneumonitis reported from heavy Cladosporium-laden indoor environments
When a patient comes in with a positive Cladosporium IgE in a panel full of other mold positives, my first question is: is this real sensitization or pan-fungal enolase cross-reactivity? Cla h 8 is the only commercially available Cladosporium component, and it helps answer that. If Alternaria is also positive, I typically treat with Alternaria SCIT — it covers the shared enolase pathway — and avoid adding Cladosporium extract to the vial, where the evidence is thin and the systemic-reaction rate is higher.
When & Where Cladosporium Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: June through August outdoors; counts can reach 15,000–50,000 spores/m³ in temperate regions· ~5 months of outdoor significance (May–September); growth continues at refrigerator temperatures (−6°C to −10°C)
US Exposure Map
12 high-intensity statesWhat Cladosporium Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Cladosporium cross-reactivity is dominated by two pan-fungal allergen families — enolase (Cla h 6) and serine protease (Cla h 9) — that are shared with Alternaria, Aspergillus, and Penicillium, complicating interpretation of multi-mold IgE panels.
Cla h 8 / Alt a 8 mannitol dehydrogenase at 85.7% identity; Cla h 6 / Alt a 6 enolase cross-reactive (79–94% identity)
Both Dothideomycetes; shared melanized cell-wall epitopes; both colonize indoor moist surfaces
Pan-fungal enolase cross-reactivity (Cla h 6 / Asp f 22); Cla h 9 serine protease overlaps with Asp f 18
Cla h 9 / Pen ch 18 serine protease cross-reactivity; both colonize water-damaged indoor environments
Shared IgE-binding bands documented in atopic-fungal panels; both outdoor seasonal molds
Is SCIT Right for Your Cladosporium Allergy?
Answer five questions to understand whether Cladosporium SCIT is worth discussing with a specialist or whether another approach fits better.
How severe are your mold-season symptoms (summer)?
The Cladosporium SCIT Protocol
Cladosporium SCIT, when considered by a specialist, uses a non-standardized mold-only extract administered separately from all pollen extracts — a conservative buildup is mandatory given the elevated systemic-reaction rate documented in surveillance data.
International consensus recommends a slower buildup for Cladosporium than for pollen allergens due to higher systemic-reaction rates documented in mold-mix safety reviews. Rush or cluster schedules are not advisable. Each injection requires a 30-minute observation period — with Curex's at-home protocol you self-observe with a prescribed epinephrine auto-injector on hand, and the first injection and every dose change are Zoom-supervised by the care team. The non-standardized nature of US extracts means Alt a 1-equivalent protein content is unknown — dose titration is based entirely on the manufacturer's weight-volume specification.
Maintenance dosing is reached after successful build-up. Mold-only vials are kept separate from any pollen vials (protease degradation rule). The limited trial evidence (Dreborg 1986, 16 children) does not define an optimal maintenance dose for Cladosporium. Your allergist will individualize the dose based on tolerability and symptom response.
Given the absence of long-term RCT data, the durability of Cladosporium SCIT response is unknown. Decisions about stopping are individualized. If Alternaria SCIT was run in parallel and is the documented primary driver of improvement, Cladosporium extract may be discontinued first.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Cladosporium SCIT
Cladosporium SCIT has essentially no modern RCT evidence — only one early controlled trial exists, and it is too small to support a clinical recommendation.
- Symptom score reduction in only published controlled trial40%Dreborg S et al., 1986, DBPC SCIT trial in children, N=16 — significant per protocol but small n and high systemic-reaction rate
- Thunderstorm asthma OR reduction with Alternaria SCIT (cross-coverage estimate)35%Pulimood TB et al., JACI 2007 — co-sensitization Alternaria + Cladosporium drives OR 63.97; Alternaria SCIT addresses shared enolase/mannitol-dehydrogenase pathway
No modern DBPC-RCT supports Cladosporium SCIT. The AAAAI/ACAAI Practice Parameter (Cox 2011) and EAACI position papers do not recommend Cladosporium SCIT as first-line; mold-mix extracts containing Cladosporium account for a disproportionate share of systemic reactions in US surveillance data. Environmental control and optimized pharmacotherapy remain the primary evidence-based interventions.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Cladosporium SCIT Side Effects
Cladosporium SCIT carries a higher systemic-reaction rate than pollen-based SCIT — a key safety consideration when weighing the thin efficacy evidence.
Local reactions
4 documentedSystemic reactions
4 documentedCladosporium is consistently associated with higher systemic-reaction rates in SCIT safety surveillance compared to pollen allergens — a meaningful counterweight to its thin efficacy data. The risk-benefit ratio is less favorable than for Alternaria SCIT or for well-standardized pollen immunotherapy.
SCIT vs Alternatives for Cladosporium
For Cladosporium-sensitive patients, the evidence actually tilts toward environmental control and optimized medications rather than SCIT — unlike most other inhalant allergens where immunotherapy is a strong first-line option.
| Criterion | SCIT | SLIT Drops | AvoidanceBest | Medications |
|---|---|---|---|---|
| Effectiveness | Very limited — 1 small trial (Dreborg 1986) | No high-quality trial data for Cladosporium | Meaningful — reducing peak exposure below 3,000 spores/m³ clinical threshold | Good symptom control for mild-to-moderate disease |
| 5-yr cost | $3,500–$15,000 total | $129/month via Curex | Low — HEPA, monitoring apps | $500–$2,000/year |
| Duration | 3–5 years maintenance | 3–5 years typical | Ongoing — lifestyle modification | Every season indefinitely |
| Convenience | Weekly then monthly clinic visits | Daily at-home drops | Moderate burden | Daily pills and sprays |
| Safety | Higher systemic-reaction rate than pollen SCIT | Low systemic risk | No injection risk | Generally safe |
| Lasting effect | Unknown — no long-term follow-up | Unknown | Sustained with continued control | No disease modification |
SCIT
SLIT Drops
AvoidanceBest
Medications
Given the thin evidence for Cladosporium SCIT, environmental control (HEPA filtration, limiting outdoor exposure above 3,000 spores/m³) and optimized antihistamines and nasal steroids are the best-evidenced interventions. If immunotherapy is pursued, Curex delivers it as weekly at-home self-injections at $129/month with allergist oversight via telehealth, a prescribed epinephrine auto-injector confirmed on hand, and Zoom-supervised dosing for the first injection and every dose change — though high-quality Cladosporium-specific immunotherapy data are also lacking.
What Cladosporium SCIT Actually Costs
Cladosporium SCIT may require additional prior-authorization documentation given that consensus guidelines do not list it as a recommended first-line treatment; your allergist may need to provide a detailed letter of medical necessity. Coverage policies vary by insurer — confirm before beginning a course. Curex at-home IgE testing identifies specific cladosporium sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your cladosporium allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Cladosporium SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Cladosporium is the most frequently occurring fungal genus in outdoor air worldwide, with counts reaching 15,000–50,000 spores/m³ in summer — far higher than any pollen. However, allergenic potency per spore is much lower than Alternaria. The clinical-significance threshold for Cladosporium symptoms is approximately 3,000 spores/m³, compared to only 100 spores/m³ for Alternaria. This means Alternaria triggers reactions at far lower concentrations. The combination of both sensitizations dramatically increases risk — Pulimood 2007 found that co-sensitization to Alternaria and Cladosporium raised thunderstorm asthma odds ratio to 63.97, compared to 9.31 for Alternaria alone. Abundance in air does not equal severity of individual allergic response.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.